Proteint
Shuanggang
About Proteint
Proteint engages in the multi-omics field of precision medicine. Their research and development pipeline covers screening and diagnosis, recurrence monitoring, and companion diagnostic services for common cancers such as liver cancer, lung cancer, gastric cancer, esophageal cancer, colorectal cancer, pancreatic cancer, pan-cancer types, cardiovascular diseases, and cerebrovascular diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Total funding: $455.9K
- Funding stage: Seed
- Last round: Angel (Feb 2016)
- Website: proteint.com
- Phone: 86-022-58096699
Industries & Categories
Health Care, Medical Device, Sales
Social Profiles
Canonical: https://fsome.com/organization/proteint-2240925 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.